TPG Capital offered Exactech $737 million to buy the medical device company, an increase to its initial offer in October, according to Reuters.
Here are three notes:
1. The $49.25 per share offer from TPG Capital is a 17.3 percent increase to its $42 per share offer in October.
2. Exatech's board agreed to the amended terms and expects to close the all-cash deal during the first quarter of 2018.
3. When the deal was announced Oct. 23, Exatech's stock has hovered at $42. However, on Monday, Dec. 4, the company's stock was trading at $49.25.